In today’s blog, it is our pleasure to introduce you to Alice Le Meur, Head of Clinical Operations.
Hi Alice, Can you tell us what is your role at SparingVision?
I am the Head of Clinical Operations, leading a team of four Clinical Project Managers who oversee the planning and execution of SparingVision’s clinical trials. My role is to ensure our studies are designed and conducted efficiently, compliantly, and with the highest scientific and operational standards.
What inspired you to join the genomic medicine in ophthalmic industry, and what keeps you motivated?
I began my clinical career in gene therapy at a time when the field was re-emerging after early-generation challenges. It was an exciting period, as we were building knowledge and expertise, alongside our partners and stakeholders. After gaining extensive experience in the central nervous system field, I was eager to move into ophthalmology—another highly specialized and complex area, with its own unique challenges and opportunities.
What do you do in your department at SparingVision?
Our team is responsible for the end-to-end execution of all SparingVision’s clinical trials. We contribute to shaping the overall clinical development strategy and manage the external partners and vendors who support our clinical activities.
How do you work with different teams across the company?
As the Head of Clinical Operations, I ensure that the Clinical Operations Department fosters close collaboration cross-functionally with nearly every department at SparingVision to ensure global alignment. From the preclinical team for benefit–risk assessment and dose selection, to the CMC and logistics groups to ensure timely product delivery to clinical sites, but also with the regulatory affairs team to prepare submissions for health authorities.
We always say everything at SparingVision starts with the patient. What does that mean in your role?
At its core, developing a treatment ultimately means improving patients’ lives. In Clinical Operations, patients are central to everything we do. Clinical research would not be possible without the participation and trust of patients and their families and this responsibility guides our decision every day.
In a few words, why did you choose to work for SparingVision?
I truly value working at SparingVision because of the strong alignment around a clear and meaningful mission: developing solutions for patients with rare diseases who currently have no therapeutic options.
